📖

SOD1-Targeting Therapies for ALS

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-sod1-targeting-therapi

Related Entities

therapeutics-sod1-targeting-therapies

Metadata

slug	therapeutics-sod1-targeting-therapies
entity_type	therapeutic
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (279)

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di75%

mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%

mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%

mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%

mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di67%

related🧫s:** - Temporal analysis showing mitochondrial defects prece63%

related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition63%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%

related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%

related🧫Metabolic Pathway-Targeted Therapy in ALS60%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%

related🧫Brainstem Circuit Modulation for PSP60%

related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%

related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%

related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%

related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%

related🧫N-of-1 Clinical Trial Design for CBS/PSP60%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%

related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%

related🧫Progranulin Replacement Therapy for FTD — Vector Development60%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%

related🧫PSP and CBS Biomarker Validation Study60%

related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%

related🧫TDP-43 PET Ligand Development for FTD and ALS60%

related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%

related🧫Metabolic Pathway-Targeted Therapy in ALS54%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%

related🧫Brainstem Circuit Modulation for PSP54%

related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%

related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%

related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%

related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%

related🧫N-of-1 Clinical Trial Design for CBS/PSP54%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%

related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%

related🧫Progranulin Replacement Therapy for FTD — Vector Development54%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%

related🧫PSP and CBS Biomarker Validation Study54%

related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%

related🧫TDP-43 PET Ligand Development for FTD and ALS54%

related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP50%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧪APOE Isoform Conversion Therapy50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Temporal Decoupling via Circadian Clock Reset50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%

mentions🧪Stress Granule Phase Separation Modulators50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

mentions🧪Phase-Separated Organelle Targeting50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬What are the most promising therapeutic strategies for targe50%

related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%

related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%

see_also📖Exosomal Biomarkers in Neurodegeneration45%

see_also📖Exosomal miR-155 in Neurodegeneration45%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%

see_also📖Liquid Biopsy in Neurodegeneration45%

see_also📖Metabolomic Biomarkers in Neurodegeneration45%

see_also📖Neuroimaging Biomarkers for Neurodegeneration45%

see_also📖Synaptic Biomarkers in Neurodegeneration45%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%

see_also📖China Neurodegeneration Epidemiology45%

see_also📖DALY Methodology — Neurodegeneration45%

see_also📖Disease Progression & Staging in Neurodegeneration45%

see_also📖Economic Burden — Neurodegeneration45%

see_also📖European Neurodegeneration Epidemiology45%

see_also📖Familial vs Sporadic Neurodegeneration Comparison45%

see_also📖Global Neurodegeneration Epidemiology45%

see_also📖India Neurodegeneration Epidemiology45%

see_also📖Japan Neurodegeneration Epidemiology45%

see_also📖Manganese-Related Neurodegeneration (Manganism)45%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%

see_also📖Potential Impact Measures — Neurodegeneration45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%

see_also📖Sleep Disorders in Neurodegeneration45%

see_also📖US Neurodegeneration Epidemiology45%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%

see_also📖acetylcholine-signaling-neurodegeneration45%

see_also📖Advanced Glycation End Products in Neurodegeneration45%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%

see_also📖Amylin Signaling in Neurodegeneration45%

see_also📖Antibody Therapy in Neurodegeneration45%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%

see_also📖Autosis Pathway in Neurodegeneration45%

see_also📖Axon Guidance Pathways in Neurodegeneration45%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%

see_also📖CaMKII Signaling Pathway in Neurodegeneration45%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%

see_also📖Cholinergic System Dysfunction in Neurodegeneration45%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%

see_also📖Neural Circuits in Neurodegeneration45%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%

see_also📖Computational Disease Models for Neurodegeneration45%

see_also📖Convergent Pathways in Neurodegeneration45%

see_also📖Copper Homeostasis in Neurodegeneration45%

see_also📖COVID-19 Neurodegeneration Mechanism45%

see_also📖Diffusion MRI (DTI) in Neurodegeneration45%

see_also📖Digital Phenotyping in Neurodegeneration45%

see_also📖Down Syndrome Neurodegeneration Pathway45%

see_also📖Dystrophic Neurites in Neurodegeneration45%

see_also📖Endocannabinoid System in Neurodegeneration45%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%

see_also📖Endosomal Sorting Defects in Neurodegeneration45%

see_also📖Endothelin Signaling Pathway in Neurodegeneration45%

see_also📖epigenetics-neurodegeneration45%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%

see_also📖FA2H-Associated Neurodegeneration Pathway45%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%

see_also📖Galectin-3 Mechanism in Neurodegeneration45%

see_also📖Gangliosides in Neurodegeneration45%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%

see_also📖GDNF Signaling Pathway in Neurodegeneration45%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%

see_also📖Glycosylation in Neurodegeneration45%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%

see_also📖Hippocampal Neurogenesis in Neurodegeneration45%

see_also📖Histone Modification Pathways in Neurodegeneration45%

see_also📖HMGB1 Signaling in Neurodegeneration45%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%

see_also📖IL-1 Signaling Pathway in Neurodegeneration45%

see_also📖Integrated Stress Response in Neurodegeneration45%

see_also📖interleukin-6-signaling-neurodegeneration45%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%

see_also📖Kidney-Brain Neurodegeneration Axis45%

see_also📖Lipid Dysregulation in Neurodegeneration45%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%

see_also📖Metal Homeostasis in Neurodegeneration45%

see_also📖Microglial Priming Pathway in Neurodegeneration45%

see_also📖MicroRNA Dysfunction in Neurodegeneration45%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%

see_also📖Mitochondrial Fusion in Neurodegeneration45%

see_also📖Molecular Chaperones in Neurodegeneration45%

see_also📖mTOR Signaling in Neurodegeneration45%

see_also📖mTOR Signaling Pathway in Neurodegeneration45%

see_also📖Neural Circuit Disruption in Neurodegeneration45%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%

see_also📖Neuronal Hyperexcitability in Neurodegeneration45%

see_also📖Neuropil Threads in Neurodegeneration45%

see_also📖Neurotensin Signaling in Neurodegeneration45%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%

see_also📖NF-kB Signaling Pathway in Neurodegeneration45%

see_also📖Nitric Oxide Signaling in Neurodegeneration45%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%

see_also📖Neuropeptide Y Signaling in Neurodegeneration45%

see_also📖NRF2 Signaling Pathway in Neurodegeneration45%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%

see_also📖Orexin Signaling in Neurodegeneration45%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%

see_also📖Paranodal Dysfunction in Neurodegeneration45%

see_also📖Paraptosis in Neurodegeneration45%

see_also📖Parthanatos in Neurodegeneration45%

see_also📖Pericyte Loss in Neurodegeneration45%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%

see_also📖PKR Pathway in Neurodegeneration45%

see_also📖PPAR Signaling Pathway in Neurodegeneration45%

see_also📖Prion Diseases in Neurodegeneration45%

see_also📖Prion-Like Spread in Neurodegeneration45%

see_also📖Prion Protein Metabolism in Neurodegeneration45%

see_also📖Progesterone Signaling Pathway in Neurodegeneration45%

see_also📖Prognostic Biomarkers in Neurodegeneration45%

see_also📖Protein Aggregation Comparison in Neurodegeneration45%

see_also📖Protein Aggregation Seeds in Neurodegeneration45%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%

see_also📖Purinergic Signaling in Neurodegeneration45%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%

see_also📖R-Loop Stress in Neurodegeneration45%

see_also📖RAN Translation in Neurodegeneration45%

see_also📖Retinal Degeneration Pathway in Neurodegeneration45%

see_also📖Ribosome Dysfunction in Neurodegeneration45%

see_also📖RNA Splicing in Neurodegeneration45%

see_also📖RNA-Targeted Therapies in Neurodegeneration45%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%

see_also📖Senescent Cell Clearance in Neurodegeneration45%

see_also📖Serotonergic Dysfunction in Neurodegeneration45%

see_also📖Sex Differences in Neurodegeneration45%

see_also📖Short Chain Fatty Acids in Neurodegeneration45%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%

see_also📖Sleep Dysfunction in Neurodegeneration45%

see_also📖SUMOylation in Neurodegeneration45%

see_also📖synaptic-vesicle-cycling-neurodegeneration45%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%

see_also📖T-Cell Dysfunction in Neurodegeneration45%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%

see_also📖Therapeutic Targets in Neurodegeneration45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%

see_also📖Vagus Nerve Pathway in Neurodegeneration45%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%

see_also📖WNK1 Kinase in Neurodegeneration45%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%

mentions🧫Multi-omics analysis of myricanol effects on gene expression44%

mentions🧫Alpha-Synuclein Seed Amplification Assay Validation44%

mentions🧫Parkinson's Disease Subtype Classification — Precision 44%

mentions🧫Prodromal Parkinson's Disease Biomarker Development — E44%

mentions🔬What are the mechanisms underlying apoe4 structural biology 40%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%

mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%

related🧪Phase-Separated Organelle Targeting40%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer35%

related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar35%

related🧪Proteostasis Enhancement via APOE Chaperone Targeting35%

related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro35%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization35%

related🧪Phase-Separated Organelle Targeting35%

SOD1-Targeting Therapies for ALS

💬 Discussion